State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Melanoma of the Skin (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.2 to 3.2 and 12,247 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 14.1

Utah³

• Rate : The incidence rate is 4.6 with a 95% confidence interval from 4.2 to 5.0 and 133 average annual cases over 2017-2021.
• CI*Rank ⋔ : 1 (1, 7)
• Percent of Cases with Late Stage : 11.2

New Hampshire⁶

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 3.9 to 4.9 and 78 average annual cases over 2017-2021.
• CI*Rank ⋔ : 2 (1, 17)
• Percent of Cases with Late Stage : 14.2

West Virginia⁶

• Rate : The incidence rate is 4.2 with a 95% confidence interval from 3.8 to 4.6 and 101 average annual cases over 2017-2021.
• CI*Rank ⋔ : 3 (1, 18)
• Percent of Cases with Late Stage : 18.2

Ohio⁶

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 4.0 to 4.3 and 591 average annual cases over 2017-2021.
• CI*Rank ⋔ : 4 (2, 11)
• Percent of Cases with Late Stage : 16.1

Delaware⁶

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.6 to 4.7 and 52 average annual cases over 2017-2021.
• CI*Rank ⋔ : 5 (1, 26)
• Percent of Cases with Late Stage : 14.8

Vermont⁶

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.4 to 4.7 and 34 average annual cases over 2017-2021.
• CI*Rank ⋔ : 6 (1, 35)
• Percent of Cases with Late Stage : 11.3

Iowa³

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.7 to 4.3 and 152 average annual cases over 2017-2021.
• CI*Rank ⋔ : 7 (2, 21)
• Percent of Cases with Late Stage : 13.0

Kentucky³

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.7 to 4.2 and 208 average annual cases over 2017-2021.
• CI*Rank ⋔ : 8 (2, 19)
• Percent of Cases with Late Stage : 14.0

Montana⁶

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.4 to 4.4 and 53 average annual cases over 2017-2021.
• CI*Rank ⋔ : 9 (1, 32)
• Percent of Cases with Late Stage : 14.1

Idaho³

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.5 to 4.3 and 80 average annual cases over 2017-2021.
• CI*Rank ⋔ : 10 (2, 26)
• Percent of Cases with Late Stage : 12.7

Wisconsin⁶

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.7 to 4.1 and 278 average annual cases over 2017-2021.
• CI*Rank ⋔ : 11 (4, 20)
• Percent of Cases with Late Stage : 16.0

South Dakota⁶

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.3 to 4.5 and 38 average annual cases over 2017-2021.
• CI*Rank ⋔ : 12 (1, 37)
• Percent of Cases with Late Stage : 12.9

Nebraska⁶

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.5 to 4.3 and 84 average annual cases over 2017-2021.
• CI*Rank ⋔ : 13 (2, 27)
• Percent of Cases with Late Stage : 13.5

Florida⁶

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.7 to 4.0 and 1,142 average annual cases over 2017-2021.
• CI*Rank ⋔ : 14 (6, 18)
• Percent of Cases with Late Stage : 14.6

Maine⁶

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.3 to 4.2 and 69 average annual cases over 2017-2021.
• CI*Rank ⋔ : 15 (2, 33)
• Percent of Cases with Late Stage : 13.7

Wyoming⁶

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.1 to 4.4 and 25 average annual cases over 2017-2021.
• CI*Rank ⋔ : 16 (1, 42)
• Percent of Cases with Late Stage : 14.6

Colorado⁶

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.5 to 3.9 and 231 average annual cases over 2017-2021.
• CI*Rank ⋔ : 17 (6, 25)
• Percent of Cases with Late Stage : 17.2

Tennessee⁶

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.5 to 3.9 and 296 average annual cases over 2017-2021.
• CI*Rank ⋔ : 18 (7, 25)
• Percent of Cases with Late Stage : 17.8

Oklahoma⁶

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.8 and 156 average annual cases over 2017-2021.
• CI*Rank ⋔ : 19 (9, 32)
• Percent of Cases with Late Stage : 16.6

Pennsylvania⁶

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.6 and 580 average annual cases over 2017-2021.
• CI*Rank ⋔ : 20 (15, 29)
• Percent of Cases with Late Stage : 17.2

Missouri⁶

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.7 and 251 average annual cases over 2017-2021.
• CI*Rank ⋔ : 21 (13, 31)
• Percent of Cases with Late Stage : 17.9

Minnesota⁶

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.2 to 3.7 and 223 average annual cases over 2017-2021.
• CI*Rank ⋔ : 22 (13, 32)
• Percent of Cases with Late Stage : 9.1

Michigan⁶

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.3 to 3.6 and 415 average annual cases over 2017-2021.
• CI*Rank ⋔ : 23 (15, 30)
• Percent of Cases with Late Stage : 16.6

Kansas⁶

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.1 to 3.7 and 113 average annual cases over 2017-2021.
• CI*Rank ⋔ : 24 (10, 38)
• Percent of Cases with Late Stage : 12.4

Rhode Island⁶

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.0 to 3.9 and 47 average annual cases over 2017-2021.
• CI*Rank ⋔ : 25 (6, 44)
• Percent of Cases with Late Stage : 17.0

North Dakota⁶

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 2.8 to 4.0 and 29 average annual cases over 2017-2021.
• CI*Rank ⋔ : 26 (3, 46)
• Percent of Cases with Late Stage : 13.5

Mississippi⁶

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.1 to 3.7 and 113 average annual cases over 2017-2021.
• CI*Rank ⋔ : 27 (11, 38)
• Percent of Cases with Late Stage : 17.2

North Carolina⁶

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.4 and 400 average annual cases over 2017-2021.
• CI*Rank ⋔ : 28 (20, 36)
• Percent of Cases with Late Stage : 12.1

South Carolina⁶

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.4 and 200 average annual cases over 2017-2021.
• CI*Rank ⋔ : 29 (18, 39)
• Percent of Cases with Late Stage : 14.0

Washington⁵

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.4 and 278 average annual cases over 2017-2021.
• CI*Rank ⋔ : 30 (21, 39)
• Percent of Cases with Late Stage : 12.4

Illinois³

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 3.0 to 3.3 and 470 average annual cases over 2017-2021.
• CI*Rank ⋔ : 31 (25, 39)
• Percent of Cases with Late Stage : 13.7

Alabama⁶

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.3 and 187 average annual cases over 2017-2021.
• CI*Rank ⋔ : 32 (23, 42)
• Percent of Cases with Late Stage : 14.7

Arkansas⁶

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.8 to 3.4 and 111 average annual cases over 2017-2021.
• CI*Rank ⋔ : 33 (20, 44)
• Percent of Cases with Late Stage : 13.9

Virginia⁶

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.2 and 304 average annual cases over 2017-2021.
• CI*Rank ⋔ : 35 (25, 41)
• Percent of Cases with Late Stage : 14.3

Arizona⁶

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.2 and 268 average annual cases over 2017-2021.
• CI*Rank ⋔ : 36 (25, 41)
• Percent of Cases with Late Stage : 9.7

Oregon⁶

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.8 to 3.2 and 154 average annual cases over 2017-2021.
• CI*Rank ⋔ : 37 (25, 45)
• Percent of Cases with Late Stage : 12.6

Georgia³

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.8 to 3.1 and 343 average annual cases over 2017-2021.
• CI*Rank ⋔ : 38 (28, 43)
• Percent of Cases with Late Stage : 11.8

Connecticut³

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.7 to 3.2 and 133 average annual cases over 2017-2021.
• CI*Rank ⋔ : 39 (26, 46)
• Percent of Cases with Late Stage : 15.6

California³

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.8 to 3.0 and 1,278 average annual cases over 2017-2021.
• CI*Rank ⋔ : 40 (35, 43)
• Percent of Cases with Late Stage : 12.7

Hawaii³

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.4 to 3.1 and 52 average annual cases over 2017-2021.
• CI*Rank ⋔ : 41 (25, 49)
• Percent of Cases with Late Stage : 11.5

Texas³

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.6 to 2.8 and 786 average annual cases over 2017-2021.
• CI*Rank ⋔ : 42 (39, 47)
• Percent of Cases with Late Stage : 18.2

Nevada⁶

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.5 to 3.0 and 96 average annual cases over 2017-2021.
• CI*Rank ⋔ : 43 (33, 48)
• Percent of Cases with Late Stage : 11.8

New Jersey³

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.6 to 2.8 and 308 average annual cases over 2017-2021.
• CI*Rank ⋔ : 44 (39, 48)
• Percent of Cases with Late Stage : 13.1

Louisiana³

• Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.4 to 2.9 and 141 average annual cases over 2017-2021.
• CI*Rank ⋔ : 45 (38, 48)
• Percent of Cases with Late Stage : 14.7

New Mexico³

• Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.3 to 2.9 and 68 average annual cases over 2017-2021.
• CI*Rank ⋔ : 46 (34, 49)
• Percent of Cases with Late Stage : 15.0

Maryland⁶

• Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.4 to 2.7 and 185 average annual cases over 2017-2021.
• CI*Rank ⋔ : 47 (40, 49)
• Percent of Cases with Late Stage : 10.3

New York³

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.4 to 2.6 and 619 average annual cases over 2017-2021.
• CI*Rank ⋔ : 48 (44, 49)
• Percent of Cases with Late Stage : 14.5

Alaska⁶

• Rate : The incidence rate is 2.0 with a 95% confidence interval from 1.5 to 2.5 and 15 average annual cases over 2017-2021.
• CI*Rank ⋔ : 49 (43, 50)
• Percent of Cases with Late Stage : 13.6

District of Columbia⁶

• Rate : The incidence rate is 1.6 with a 95% confidence interval from 1.2 to 2.1 and 10 average annual cases over 2017-2021.
• CI*Rank ⋔ : 50 (49, 50)
• Percent of Cases with Late Stage : 15.3

Puerto Rico⁶

• Rate : The incidence rate is 0.6 with a 95% confidence interval from 0.5 to 0.7 and 26 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 19.7

Indiana⁶

• Rate : Data not available for this combination of data selections.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : data not available

Notes:
Created by statecancerprofiles.cancer.gov on 10/03/2024 10:59 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
³ Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
⁵ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
⁶ Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.